GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bonesupport Holding AB (CHIX:BONEXs) » Definitions » Capital Expenditure

Bonesupport Holding AB (CHIX:BONEXS) Capital Expenditure : kr-7.55 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bonesupport Holding AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Bonesupport Holding AB's cash flow for capital expenditures for the three months ended in Mar. 2024 was kr-1.9 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was kr-7.55 Mil.

Bonesupport Holding AB Capital Expenditure Historical Data

The historical data trend for Bonesupport Holding AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonesupport Holding AB Capital Expenditure Chart

Bonesupport Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.43 -2.66 -3.42 -3.28 -6.06

Bonesupport Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 -1.03 -0.57 -4.03 -1.93

Bonesupport Holding AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-7.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB (CHIX:BONEXS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bonesupport Holding AB (CHIX:BONEXs) » Definitions » Capital Expenditure
Comparable Companies
OSTO:BIOT OSTO:ALIF B OSTO:SYNSAM OSTO:TDVOX OSTO:ADDV A OSTO:ELOS B OSTO:DOXA OSTO:QLINEA XSAT:BPCINS OSTO:ORTI A ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
BOEUF:USA BONEX:Sweden 2B4:Germany
Address
Scheelevagen 19, Lund, SWE, SE-223 70
Website
https://www.bonesupport.com
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and sells injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and has the ability to release pharmaceuticals to promote healing. Its products focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: North America (NA) and Europe & Rest of the World (EUROW).

Bonesupport Holding AB (CHIX:BONEXS) Headlines

No Headlines